共 8 条
- [1] A Randomized Controlled Trial in Second-Generation Zotarolimus-Eluting Resolute Stents Versus Everolimus-Eluting Xience V Stents in Real-World Patients The TWENTE TrialJOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2012, 59 (15) : 1350 - 1361von Birgelen, ClemensBasalus, Mounir W. Z.Tandjung, Kennethvan Houwelingen, K. GertStoel, Martin G.Louwerenburg, J. W.Linssen, Gerard C. M.Said, Salah A. M.Kleijne, Miep A. W. J.Sen, HanimLowik, Marije M.van der Palen, JobVerhorst, Patrick M. J.de Man, Frits H. A. F.
- [2] Women treated with second-generation zotarolimus-eluting resolute stents and everolimus-eluting xience V stents: insights from the gender-stratified, randomized, controlled TWENTE trialCATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2013, 82 (03) : 396 - 405Tandjung, KennethBasalus, Mounir W. Z.Sen, HanimStoel, Martin G.van Houwelingen, K. GertLouwerenburg, J. W.de Man, Frits H. A. F.Linssen, Gerard C. M.Said, Salah A. M.Kleijne, Miep A. W. J.van der Palen, Jobvon Birgelen, Clemens
- [3] Two-year clinical outcomes of patients with overlapping second-generation drug-eluting stents for treatment of long coronary artery lesions: comparison of everolimus-eluting stents with resolute zotarolimus-eluting stentsCORONARY ARTERY DISEASE, 2014, 25 (05) : 405 - 411Li, Xiao-taoSun, HaoZhang, Da-pengXu, LiNi, Zhu-huaXia, KunLiu, YuChi, Yong-huiHe, Ji-fangLi, Wei-mingWang, Hong-shiWang, Le-fengYang, Xin-chun
- [4] Clinical Outcome Following Stringent Discontinuation of Dual Antiplatelet Therapy After 12 Months in Real-World Patients Treated With Second-Generation Zotarolimus-Eluting Resolute and Everolimus-Eluting Xience V Stents 2-Year Follow-Up of the Randomized TWENTE TrialJOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2013, 61 (24) : 2406 - 2416Tandjung, KennethSen, HanimLam, Ming KaiBasalus, Mounir W. Z.Louwerenburg, J. W.Stoel, Martin G.van Houwelingen, K. Gertde Man, Frits H. A. F.Linssen, Gerard C. M.Said, Salah A. M.Nienhuis, Mark B.Lowik, Marije M.Verhorst, Patrick M. J.van der Palen, Jobvon Birgelen, Clemens
- [5] Comparison of short-term clinical outcomes between Resolute Onyx zotarolimus-eluting stents and everolimus-eluting stent in patients with acute myocardial infarction: Results from the Korea Acute Myocardial infarction Registry (KAMIR)CARDIOLOGY JOURNAL, 2019, 26 (05) : 469 - 476Kim, YongcheolOh, Sung SikJeong, Myung HoAhn, YoungkeunKim, Ju HanHong, Young JoonSim, Doo SunKim, Min ChulKim, Hyo-SooYun, Kyeong HoOh, Seok KyuKim, Chong JinCho, Myeong Chan
- [6] Clinical Outcomes in Real-World Patients With Acute Myocardial Infarction Receiving XIENCE V® Everolimus-Eluting Stents: One-Year Results From the XIENCE V USA StudyCATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2013, 82 (04) : E385 - E394Sudhir, KrishnankuttyHermiller, James B.Naidu, Srihari S.Henry, Timothy D.Mao, Vivian W.Zhao, WeiyingFerguson, Joanne M.Wang, JinJonnavithula, LalithaSimonton, Charles A.Rutledge, David R.Krucoff, Mitchell W.
- [7] Long-term performance of the second-generation cobalt-chromium sirolimus-eluting stents in real-world clinical practice: 3-year clinical outcomes from the prospective multicenter FOCUS registryJOURNAL OF THORACIC DISEASE, 2016, 8 (07) : 1601 - +Zhang, FengYang, Ji'eQian, JuyingGe, LeiZhou, JunGe, Junbo
- [8] Clinical Outcomes in Real-World Patients With Small Vessel Disease Treated With XIENCE V® Everolimus-Eluting Stents: One Year Results From the XIENCE V® USA Condition of Approval Post-Market StudyCATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2014, 84 (01) : 7 - 16Hermiller, James B.Rutledge, David R.Mao, Vivian W.Zhao, WeiyingWang, JinGruberg, LuisLombardi, WilliamSharma, Samin K.Krucoff, Mitchell W.